Recombinant activated factor VII use in critically ill patients: clinical outcomes and thromboembolic events.
Saved in:
| Title: | Recombinant activated factor VII use in critically ill patients: clinical outcomes and thromboembolic events. |
|---|---|
| Authors: | Brophy GM; Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University, Richmond, VA, USA., Candeloro CL, Robles JR, Brophy DF |
| Source: | The Annals of pharmacotherapy [Ann Pharmacother] 2013 Apr; Vol. 47 (4), pp. 447-54. Date of Electronic Publication: 2013 Mar 27. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Sage Country of Publication: United States NLM ID: 9203131 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-6270 (Electronic) Linking ISSN: 10600280 NLM ISO Abbreviation: Ann Pharmacother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
